|
|||||
|
|
Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies |
|
| Authors: | Jennifer K. Logan Soroush Rais‐Bahrami Baris Turkbey Andrew Gomella Hayet Amalou Peter L. Choyke Bradford J. Wood Peter A. Pinto |
| Affiliation: | 1. Urologic Oncology Branch, National Cancer Institute, , USA;2. Molecular Imaging Program, National Cancer Institute, , USA;3. Imaging Physics Laboratory, National Heart, Lung and Blood Institute, National Institutes of Health, , Bethesda, MD, USA;4. Center for Interventional Oncology, National Cancer Institute, , USA |
| Abstract: | Prostate MRI is currently the best diagnostic imaging method for detecting PCa. Magnetic resonance imaging (MRI)/ultrasonography (US) fusion allows the sensitivity and specificity of MRI to be combined with the real‐time capabilities of transrectal ultrasonography (TRUS). Multiple approaches and techniques exist for MRI/US fusion and include direct ‘in bore’ MRI biopsies, cognitive fusion, and MRI/US fusion via software‐based image coregistration platforms. |
| Keywords: | prostate MRI MRI/US fusion targeted biopsy MRI/US fusion platforms |